Malignancy associated hemophagocytic lymphohistiocytosis in children
Conclusion: The delay in the diagnosis of MA-HLH in pediatric patients may be due to decrease awareness about the condition the timely diagnosis of MA-HLH is crucial for a better outcome. Herein, we discuss our experience with this rare entity in pediatric oncology patients with review of literature.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Amitabh Singh Lesa Dawman Rachna Seth Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Children | Hodgkin's Disease | Leukemia | Lymphoma | Microbiology | Pediatrics | Rheumatology | Study